Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › NIH Launches $20M Competition for New Antimicrobial Resistance Diagnostics

NIH Launches $20M Competition for New Antimicrobial Resistance Diagnostics

Sep 08, 2016
|
staff reporter

NEW YORK (GenomeWeb) – The National Institutes of Health today launched a $20 million competition to promote the development of novel point-of-care in vitro diagnostics to detect and distinguish antibiotic-resistant bacteria.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. Biocartis, Exact Sciences Terminate Oncotype DX Agreement

  2. Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

  3. Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company

  4. PerkinElmer SARS-CoV-2 Test Gets Reissued Emergency Use Authorization for Pooled Sampling

  5. GenMark Q3 Revenues More Than Double on Respiratory Panel Sales

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.